Skip to main content

Table 5 Descriptive statistics comparing OPT and AIM group at baseline and early in treatment for AN/Atypical AN patients only

From: From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)—treatment course and outcomes

Characteristic

Overall

(N = 290)1

OPT group

(N = 213)1

AIM group

(N = 77)1

p Value2

Age

15 (13, 16)

15 (13, 16)

15 (13, 16)

0.2

Duration of illness

8 (5, 12)

8 (5, 13)

8 (6, 12)

0.6

Missing

19

14

5

 

Age of Onset

14 (12, 15)

14.00 (12, 15)

14 (13, 15)

0.6

Missing

15

11

4

 

EDE-Q (Global)

3.3 (1.5, 4.7)

3.1 (1.2, 4.6)

4.1 (2.5, 5.1)

0.002

Missing

44

31

13

 

MFQ

28 (18, 43)

25 (14, 40)

36 (23, 50)

 < 0.001

Missing

46

34

12

 

SCARED

27 (13, 39)

24 (12, 34)

34 (20, 43)

0.002

Missing

45

33

12

 

ChOCI

16 (5, 26)

15 (5, 25)

20 (4, 28)

0.3

Missing

92

67

25

 

QoL

5 (4, 7)

5 (4, 7)

5 (3, 7)

0.051

Missing

69

50

19

 

%mBMI at assessment

81.7 (76.1, 87.4)

82.2 (76.7, 88.6)

79.8 (72.9, 85.0)

0.007

Missing

0

0

0

 

%mBMI at 1 month

84.8 (78.2, 91.4)

85.6 (79.9, 93.0)

80.3 (74.5, 86.9)

 < 0.001

Missing

3

2

1

 

%mBMI at 3 months

87.0 (80.6, 93.5)

87.9 (82.7, 95.3)

82.7 (75.0, 90.3)

 < 0.001

Missing

22

18

4

 
  1. 1Median (IQR)
  2. 2Wilcoxon rank sum test
  3. Abbreviations: %mBMI percentage of median body mass index, AIM additional intervention management (day treatment or inpatient treatment; ChOCI Children’s obsessional compulsive, CI confidence interval, DUED duration of untreated illness prior to assessment, EDE-Q (G) eating disorder examination questionnaire global score, MFQ mood and feelings questionnaire, OPT outpatient treatment only, QoL Quality of Life, SCARED screen for child anxiety related disorder, SD standard deviation